In order to determine if the absence of methylation in the CHD5 promoter was restricted only to breast cancer, we also looked into the methylation status in other neoplasms such as Low-Grade Gliomas or Glioblastomas where we also did not find methylation at the promoter region (Supplementary Figure 1C). This evidence concerns the gene CHD5 and breast carcinoma.